Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES RHEE

Allopathic & Osteopathic Physicians Anesthesiology

NPI
1639374259
CMS profile
922049
Location
BOSTON, MA

General Payments · PY2018–2024

$32,042.92

  • Reported across 15 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$14,036.73

5 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $13,941.00 4
Food and Beverage $95.73 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $13,941.00 4
SPR Therapeutics, Inc $95.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $30.25 2
PY2023 $17,975.94 8
PY2024 $14,036.73 5

Payment records · PY2024 (5)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
SPR Therapeutics, Inc $95.73 09/13/2024 Food and Beverage Undisputed 01/23/2026 1104954344 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,575.00 03/04/2024 Consulting Fee Undisputed 01/23/2026 1137661796 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,932.00 04/22/2024 Consulting Fee Undisputed 01/23/2026 1137661798 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,502.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 1137661800 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,932.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 1137661802 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.